全文获取类型
收费全文 | 35036篇 |
免费 | 76篇 |
国内免费 | 118篇 |
专业分类
系统科学 | 338篇 |
丛书文集 | 720篇 |
教育与普及 | 87篇 |
理论与方法论 | 116篇 |
现状及发展 | 15318篇 |
研究方法 | 1399篇 |
综合类 | 16658篇 |
自然研究 | 594篇 |
出版年
2013年 | 200篇 |
2012年 | 486篇 |
2011年 | 1076篇 |
2010年 | 181篇 |
2008年 | 551篇 |
2007年 | 633篇 |
2006年 | 668篇 |
2005年 | 662篇 |
2004年 | 633篇 |
2003年 | 626篇 |
2002年 | 555篇 |
2001年 | 1067篇 |
2000年 | 1034篇 |
1999年 | 654篇 |
1992年 | 632篇 |
1991年 | 543篇 |
1990年 | 578篇 |
1989年 | 501篇 |
1988年 | 520篇 |
1987年 | 557篇 |
1986年 | 537篇 |
1985年 | 691篇 |
1984年 | 558篇 |
1983年 | 450篇 |
1982年 | 371篇 |
1981年 | 394篇 |
1980年 | 521篇 |
1979年 | 1121篇 |
1978年 | 916篇 |
1977年 | 882篇 |
1976年 | 701篇 |
1975年 | 784篇 |
1974年 | 1050篇 |
1973年 | 927篇 |
1972年 | 913篇 |
1971年 | 1115篇 |
1970年 | 1462篇 |
1969年 | 1098篇 |
1968年 | 914篇 |
1967年 | 1015篇 |
1966年 | 916篇 |
1965年 | 648篇 |
1964年 | 165篇 |
1959年 | 386篇 |
1958年 | 612篇 |
1957年 | 466篇 |
1956年 | 419篇 |
1955年 | 351篇 |
1954年 | 382篇 |
1948年 | 282篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
921.
Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins 总被引:59,自引:0,他引:59
A complementary DNA encoding the D100 polypeptide of rat brain dynamin--a force-producing, microtubule-activated nucleotide triphosphatase--has been cloned and sequenced. The predicted amino acid sequence includes a guanine nucleotide-binding domain that is homologous with those of a family of antiviral factors, inducible by interferon and known as Mx proteins, and with the product of the essential yeast vacuolar protein sorting gene VPS1. These relationships imply the existence of a new family of GTPases with physiological roles that may include microtubule-based motility and protein sorting. 相似文献
922.
氨酯键和脲键对嵌段聚氨酯和嵌段聚脲性质影响的研究 总被引:2,自引:0,他引:2
用溶液聚合法合成了四种聚氨酯、聚脲模型化合物.并用凝胶渗透色谱,应力—应变,广角X射线衍射等手段检验了在相界面或在硬段微区,不同键对聚合物分子量、力学性质和聚合物形态的影响. 相似文献
923.
GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism 总被引:11,自引:0,他引:11
Immunoglobulin A is the primary immunoglobulin isotype in tears, saliva, breast milk and other mucosal secretions, constituting between 6% and 15% of the total serum immunoglobulins. Human peripheral blood neutrophils have IgA receptors, but these cells do not normally participate in IgA-mediated phagocytosis. The haematopoietic factors granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) prime neutrophils to be more responsive to a variety of stimuli. We therefore studied their effect on IgA-mediated phagocytosis. GM-CSF and G-CSF both induce a change from low to high-affinity neutrophil IgA Fc crystallizable fragment receptors within 30 min; a change which is associated with the development of IgA-mediated phagocytosis. Human IL-3, which does not affect neutrophil function, is inactive in this system. These results define a new mechanism for CSF-augmented host defence whereby neutrophil function can be modulated by CSF-mediated IgA Fc receptor activation. 相似文献
924.
Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease 总被引:104,自引:0,他引:104
R E Tanzi A I McClatchey E D Lamperti L Villa-Komaroff J F Gusella R L Neve 《Nature》1988,331(6156):528-530
Amyloid B-protein/amyloid A4 is a peptide present in the neuritic plaques, neurofibrillary tangles and cerebrovascular deposits in patients with Alzheimer's disease and Down's syndrome (trisomy 21) and may be involved in the pathogenesis of Alzheimer's disease. Recent molecular genetic studies have indicated that amyloid protein is encoded as part of a larger protein by a gene on human chromosome 21 (refs 6-9). The amyloid protein precursor (APP) gene is expressed in brain and in several peripheral tissues, but the specific biochemical events leading to deposition of amyloid are not known. We have now screened complementary DNA libraries constructed from peripheral tissues to determine whether the messenger RNA encoding APP in these tissues is identical to that expressed in brain, and we identify a second APP mRNA that encodes an additional internal domain with a sequence characteristic of a Kunitz-type serine protease inhibitor. The alternative APP mRNA is present in both brain and peripheral tissues of normal individuals and those with Alzheimer's disease, but its pattern of expression differs from that of the previously reported APP mRNA. 相似文献
925.
926.
Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate 总被引:87,自引:0,他引:87
The generation of second messengers from the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdInsP2) by phosphoinositidase C has been implicated in the mediation of cellular responses to a variety of growth factors and oncogene products. The first step in the production of PtdInsP2 from phosphatidylinositol (PtdIns) is catalysed by PtdIns kinase. A PtdIns kinase activity has been found to associate specifically with several oncogene products, as well as with the platelet-derived growth factor (PDGF) receptor. We have previously identified two biochemically distinct PtdIns kinases in fibroblasts, and have found that only one of these, designated type I, specifically associates with activated tyrosine kinases. We have now characterized the site on the inositol ring phosphorylated by type I PtdIns kinase, and find that this kinase specifically phosphorylates the D-3 ring position to generate a novel phospholipid, phosphatidylinositol-3-phosphate (PtdIns(3)P). In contrast, the main PtdIns kinase in fibroblasts, designated type II, specifically phosphorylates the D-4 position to produce phosphatidylinositol-4-phosphate (PtdIns(4)P), previously considered to be the only form of PtdInsP. We have also tentatively identified PtdIns(3)P as a minor component of total PtdInsP in intact fibroblasts. We propose that type I PtdIns kinase is responsible for the generation of PtdIns(3)P in intact cells, and that this novel phosphoinositide could be important in the transduction of mitogenic and oncogenic signals. 相似文献
927.
The POU domain is a bipartite DNA-binding structure 总被引:48,自引:0,他引:48
928.
Multiple liquid crystal phases of DNA at high concentrations 总被引:3,自引:0,他引:3
DNA packaging in vivo is very tight, with volume concentrations approaching 70% w/v in sperm heads, virus capsids and bacterial nucleoids. The packaging mechanisms adopted may be related to the natural tendency of semi-rigid polymers to form liquid crystalline phases in concentrated solutions. We find that DNA forms at least three distinct liquid crystalline phases at concentrations comparable to those in vivo, with phase transitions occurring over relatively narrow ranges of DNA concentration. A weakly birefringent, dynamic, 'precholesteric' mesophase with microscopic textures intermediate between those of a nematic and a true cholesteric phase forms at the lowest concentrations required for phase separation. At slightly higher DNA concentrations, a second mesophase forms which is a strongly birefringent, well-ordered cholesteric phase with a concentration-dependent pitch varying from 2 to 10 micron. At the highest DNA concentrations, a phase forms which is two-dimensionally ordered and resembles smectic phases of thermotropic liquid crystals observed with small molecules. 相似文献
929.
Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex 总被引:83,自引:0,他引:83
In mice the product of the Mlsa locus is an unusual antigen capable of interaction with certain products of the major histocompatibility locus (MHC) to form a ligand for a large portion of the T-cell alpha/beta receptor repertoire, including nearly all receptors that use V beta 8.1. The presence of Mlsa/MHC during T-cell development results in the deletion of T cells that express V beta 8.1, documenting the importance of clonal deletion in establishing tolerance to self antigens. 相似文献
930.
The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain 总被引:54,自引:0,他引:54
L P Freedman B F Luisi Z R Korszun R Basavappa P B Sigler K R Yamamoto 《Nature》1988,334(6182):543-546